You are leaving Evergreentgn.com
You have clicked on an external link and will be taken offsite.
Cancel
Confirm

News

view details
September 30, 2021

Clarity and Evergreen enter Targeted Copper Theranostics manufacturing agreement for US clinical trials
view details
August 16, 2021

Cellectar Announces Manufacturing and Supply Agreement with Evergreen Theragnostics for CLR-131, now known as iopofosine I-131
view details
July 14, 2021

Evergreen Theragnostics Expands Alpha Radiopharmaceutical Production Capabilities
view details
April 28, 2021

Precirix partners with Evergreen to expand North American clinical trial supply
view details
September 23, 2020

Evergreen Theragnostics Begins Construction of New Manufacturing Facility